AxoGen's GAAP loss for three months of 2021 was $6.66 million, down 18.7% from $8.192 million in the previous year. Revenue increased 27.9% to $31.037 million from $24.261 million a year earlier.
AxoGen's GAAP loss for three months of 2021 was $6.66 million, down 18.7% from $8.192 million in the previous year. Revenue increased 27.9% to $31.037 million from $24.261 million a year earlier. 
ir.axogeninc.com
English (US) 